Display options
Cite
Cortinovis D, Abbate M, Bidoli P, et al. Targeted therapies and immunotherapy in non-small-cell lung cancer. Ecancermedicalscience. 2016;10:648doi: 10.3332/ecancer.2016.648.
Cortinovis, D., Abbate, M., Bidoli, P., Capici, S., & Canova, S. (2016). Targeted therapies and immunotherapy in non-small-cell lung cancer. Ecancermedicalscience, 10648. https://doi.org/10.3332/ecancer.2016.648
Cortinovis, D, et al. "Targeted therapies and immunotherapy in non-small-cell lung cancer." Ecancermedicalscience vol. 10 (2016): 648. doi: https://doi.org/10.3332/ecancer.2016.648
Cortinovis D, Abbate M, Bidoli P, Capici S, Canova S. Targeted therapies and immunotherapy in non-small-cell lung cancer. Ecancermedicalscience. 2016 Jun 23;10:648. doi: 10.3332/ecancer.2016.648. eCollection 2016. PMID: 27433281; PMCID: PMC4929979.
Copy Download .nbib Format: NLM
Share it on

Ecancermedicalscience. 2016 Jun 23;10:648. doi: 10.3332/ecancer.2016.648. eCollection 2016.

Targeted therapies and immunotherapy in non-small-cell lung cancer.

Ecancermedicalscience

D Cortinovis, M Abbate, P Bidoli, S Capici, S Canova

Affiliations

  1. Medical Oncology Unit, AOU San Gerardo, via Giambattista Pergolesi 33, 20900 Monza, Italy.

PMID: 27433281 PMCID: PMC4929979 DOI: 10.3332/ecancer.2016.648

Abstract

Non-small-cell lung cancer is still considered a difficult disease to manage because of its aggressiveness and resistance to common therapies. Chemotherapy remains the gold standard in nearly 80% of lung cancers, but clinical outcomes are discouraging, and the impact on median overall survival (OS) barely reaches 12 months. At the end of the last century, the discovery of oncogene-driven tumours completely changed the therapeutic landscape in lung cancers, harbouring specific gene mutations/translocations. Epidermal growth factors receptor (EGFR) common mutations first and anaplastic lymphoma kinase (ALK) translocations later led new insights in lung cancer biology knowledge. The use of specific tyrosine kinases inhibitors overturned the biological behaviour of EGFR mutation positive tumours and became a preclinical model to understand the heterogeneity of lung cancers and the mechanisms of drug resistance. In this review, we summarise the employment of targeted agents against the most representative biomolecular alterations and provide some criticisms of the therapeutic strategies.

Keywords: immunotherapy; non-small cell lung cancer; oncogene drivers; targeted agents

References

  1. N Engl J Med. 2015 Oct 22;373(17):1627-39 - PubMed
  2. N Engl J Med. 2015 Apr 30;372(18):1700-9 - PubMed
  3. Lancet Oncol. 2012 Oct;13(10):1011-9 - PubMed
  4. Lancet Oncol. 2014 Oct;15(11):1236-44 - PubMed
  5. Mol Cancer Ther. 2014 Dec;13(12 ):2910-8 - PubMed
  6. J Clin Oncol. 2012 Jun 1;30(16):e147-50 - PubMed
  7. Lung Cancer. 2015 Dec;90(3):509-15 - PubMed
  8. Cancer Lett. 2008 Jul 8;265(2):307-17 - PubMed
  9. Ann Oncol. 2016 Mar;27(3):423-9 - PubMed
  10. Clin Cancer Res. 2014 Mar 15;20(6):1698-705 - PubMed
  11. Int J Oncol. 2014 Oct;45(4):1430-6 - PubMed
  12. Lancet Oncol. 2014 Sep;15(10):1119-28 - PubMed
  13. J Clin Oncol. 2013 Sep 20;31(27):3327-34 - PubMed
  14. Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19893-7 - PubMed
  15. Cancer Sci. 2012 Oct;103(10):1795-802 - PubMed
  16. J Clin Oncol. 2013 Jul 10;31(20):e341-4 - PubMed
  17. Lancet Oncol. 2016 Feb;17 (2):234-42 - PubMed
  18. Nat Med. 2014 Sep;20(9):1027-34 - PubMed
  19. J Thorac Oncol. 2008 Jan;3(1):13-7 - PubMed
  20. N Engl J Med. 2010 Jun 24;362(25):2380-8 - PubMed
  21. Int J Cancer. 1998 Jan 19;75(2):171-5 - PubMed
  22. J Clin Oncol. 2015 Nov 10;33(32):3701-9 - PubMed
  23. N Engl J Med. 2014 Dec 4;371(23):2167-77 - PubMed
  24. J Thorac Oncol. 2014 Dec;9(12):1821-5 - PubMed
  25. Cancer Discov. 2013 Dec;3(12):1355-63 - PubMed
  26. Clin Cancer Res. 2005 Mar 1;11(5):1983-9 - PubMed
  27. Science. 2015 Apr 3;348(6230):124-8 - PubMed
  28. Nature. 2002 Jun 27;417(6892):949-54 - PubMed
  29. Transl Lung Cancer Res. 2013 Apr;2(2):122-7 - PubMed
  30. Lancet Oncol. 2013 Jul;14(8):777-86 - PubMed
  31. Ann Oncol. 2016 Mar;27(3):417-23 - PubMed
  32. Lancet Oncol. 2015 Aug;16(8):990-8 - PubMed
  33. JAMA Oncol. 2016 Mar;2(3):305-12 - PubMed
  34. Lung Cancer. 2012 Apr;76(1):123-7 - PubMed
  35. J Clin Oncol. 2016 Mar 1;34(7):661-8 - PubMed
  36. J Thorac Oncol. 2015 Nov;10(11):1546-52 - PubMed
  37. Clin Cancer Res. 2007 Sep 1;13(17 ):5150-5 - PubMed
  38. Oncol Lett. 2012 Jul;4(1):89-93 - PubMed
  39. Clin Lung Cancer. 2014 Jan;15(1):1-6 - PubMed
  40. J Clin Oncol. 2015 Aug 20;33(24):2667-74 - PubMed
  41. Cancer Discov. 2013 Jun;3(6):630-5 - PubMed
  42. Lancet Oncol. 2015 Oct;16(13):e510-21 - PubMed
  43. Nat Rev Clin Oncol. 2012 Apr 03;9(5):268-77 - PubMed
  44. J Clin Oncol. 2016 Aug 20;34(24):2858-65 - PubMed
  45. Lancet Oncol. 2012 Mar;13(3):239-46 - PubMed
  46. Lung Cancer. 2015 Feb;87(2):89-95 - PubMed
  47. J Clin Oncol. 2013 Mar 10;31(8):1070-80 - PubMed
  48. J Thorac Oncol. 2015 Sep;10(9):1268-78 - PubMed
  49. J Thorac Oncol. 2012 Jan;7(1):98-104 - PubMed
  50. J Clin Oncol. 2016 May 20;34(15):e141-4 - PubMed
  51. Lancet Oncol. 2013 Jan;14 (1):38-47 - PubMed
  52. Exp Ther Med. 2015 Jun;9(6):2151-2154 - PubMed
  53. Lung Cancer. 2015 Nov;90(2):255-60 - PubMed
  54. Lancet Oncol. 2012 May;13(5):528-38 - PubMed
  55. Clin Cancer Res. 2013 Aug 1;19(15):4273-81 - PubMed
  56. Clin Cancer Res. 2012 Mar 1;18(5):1472-82 - PubMed
  57. Clin Cancer Res. 2015 Jan 1;21(1):166-74 - PubMed
  58. Cancer. 2005 Nov 15;104(10):2149-55 - PubMed
  59. J Clin Oncol. 2015 Nov 10;33(32):3681-3 - PubMed
  60. N Engl J Med. 2014 Nov 20;371(21):1963-71 - PubMed
  61. Cancer Discov. 2014 Jun;4(6):662-73 - PubMed
  62. J Thorac Oncol. 2014 Apr;9(4):549-53 - PubMed
  63. N Engl J Med. 2015 Apr 30;372(18):1689-99 - PubMed
  64. Lung Cancer. 2015 Nov;90(2):249-54 - PubMed
  65. Lancet Oncol. 2015 Oct;16(13):1324-34 - PubMed
  66. N Engl J Med. 2004 May 20;350(21):2129-39 - PubMed
  67. Nat Rev Genet. 2010 Oct;11(10):685-96 - PubMed
  68. Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3493-8 - PubMed
  69. N Engl J Med. 2011 Jun 30;364(26):2507-16 - PubMed
  70. J Clin Oncol. 2009 Oct 20;27(30):5080-7 - PubMed
  71. J Clin Oncol. 2013 Mar 10;31(8):1097-104 - PubMed
  72. J Clin Oncol. 2009 Sep 10;27(26):4247-53 - PubMed
  73. Clin Cancer Res. 2008 Jul 1;14(13):4275-83 - PubMed
  74. Clin Cancer Res. 2016 May 15;22(10):2386-95 - PubMed
  75. Ann Oncol. 2013 Sep;24(9):2371-6 - PubMed
  76. N Engl J Med. 2013 Jun 20;368(25):2385-94 - PubMed
  77. PLoS One. 2012;7(2):e30820 - PubMed
  78. J Clin Oncol. 2014 Nov 10;32(32):3673-9 - PubMed
  79. N Engl J Med. 2014 Mar 27;370(13):1189-97 - PubMed
  80. Lancet Oncol. 2009 May;10(5):432-3 - PubMed
  81. Oncotarget. 2016 Mar 1;7(9):9707-17 - PubMed
  82. Lancet Oncol. 2015 Jul;16(7):830-8 - PubMed
  83. Ann Oncol. 2014 Feb;25(2):415-22 - PubMed
  84. N Engl J Med. 2010 Oct 28;363(18):1693-703 - PubMed
  85. Clin Cancer Res. 2015 Dec 15;21(24):5439-44 - PubMed
  86. Lung Cancer. 2015 Feb;87(2):169-75 - PubMed
  87. Cancer Res. 2007 Mar 1;67(5):2046-53 - PubMed
  88. J Thorac Oncol. 2012 Jan;7(1):90-7 - PubMed
  89. Lancet. 2016 Apr 2;387(10026):1415-26 - PubMed
  90. Curr Opin Oncol. 2016 Mar;28(2):130-4 - PubMed
  91. Ann Oncol. 2004 Jan;15(1):19-27 - PubMed
  92. Lancet Oncol. 2014 Nov;15(12 ):1369-78 - PubMed
  93. N Engl J Med. 2015 Jul 9;373(2):123-35 - PubMed
  94. N Engl J Med. 2015 May 21;372(21):2018-28 - PubMed
  95. J Thorac Oncol. 2013 Jul;8(7):823-59 - PubMed
  96. J Clin Oncol. 2013 Nov 10;31(32):4105-14 - PubMed
  97. N Engl J Med. 2016 Jan 7;374(1):54-61 - PubMed
  98. Cancer Discov. 2016 Feb;6(2):115 - PubMed
  99. Br J Cancer. 2015 Nov 17;113(10 ):1519-28 - PubMed
  100. Nat Med. 2012 Feb 12;18(3):382-4 - PubMed
  101. Ann Oncol. 2016 Jan;27(1):185-92 - PubMed
  102. Crit Rev Oncol Hematol. 2012 Sep;83(3):407-21 - PubMed
  103. Oncol Res Treat. 2015;38(6):291-8 - PubMed
  104. Lung Cancer. 2014 Aug;85(2):326-30 - PubMed
  105. Expert Rev Anticancer Ther. 2015 May;15(5):487-9 - PubMed
  106. Lancet Oncol. 2016 May;17(5):642-50 - PubMed
  107. Br J Cancer. 2015 Jan 6;112(1):95-102 - PubMed
  108. Nature. 2007 Aug 2;448(7153):561-6 - PubMed
  109. J Clin Oncol. 2016 Jan 10;34(2):123-9 - PubMed
  110. N Engl J Med. 2014 Oct 23;371(17):1655-6 - PubMed
  111. J Clin Oncol. 2011 May 20;29(15):e443-5 - PubMed
  112. Lancet Oncol. 2015 Feb;16(2):141-51 - PubMed
  113. Lancet Oncol. 2014 Nov;15(12 ):1379-88 - PubMed
  114. Nat Med. 2015 Jun;21(6):560-2 - PubMed
  115. Lancet Oncol. 2013 Jun;14(7):590-8 - PubMed
  116. Transl Lung Cancer Res. 2013 Feb;2(1):23-39 - PubMed

Publication Types